BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36176459)

  • 1. Follicular fluid lipidomic profiling reveals potential biomarkers of polycystic ovary syndrome: A pilot study.
    Ding Y; Jiang Y; Zhu M; Zhu Q; He Y; Lu Y; Wang Y; Qi J; Feng Y; Huang R; Yin H; Li S; Sun Y
    Front Endocrinol (Lausanne); 2022; 13():960274. PubMed ID: 36176459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High coverage of targeted lipidomics revealed lipid changes in the follicular fluid of patients with insulin-resistant polycystic ovary syndrome and a positive correlation between plasmalogens and oocyte quality.
    Zhang M; Wang Y; Di J; Zhang X; Liu Y; Zhang Y; Li B; Qi S; Cao X; Liu L; Liu S; Xu F
    Front Endocrinol (Lausanne); 2024; 15():1414289. PubMed ID: 38904043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular free fatty acid metabolic signatures and their effects on oocyte competence in non-obese PCOS patients.
    Feng Y; Qi J; Xue X; Li X; Liao Y; Sun Y; Tao Y; Yin H; Liu W; Li S; Huang R
    Reproduction; 2022 May; 164(1):1-8. PubMed ID: 35521903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipidomics analysis of human follicular fluid form normal-weight patients with polycystic ovary syndrome: a pilot study.
    Ban Y; Ran H; Chen Y; Ma L
    J Ovarian Res; 2021 Oct; 14(1):135. PubMed ID: 34645507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization.
    Niu Z; Lin N; Gu R; Sun Y; Feng Y
    J Clin Endocrinol Metab; 2014 Nov; 99(11):E2269-76. PubMed ID: 24694334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers identification in follicular fluid in relation to live birth in in vitro fertilization of women with polycystic ovary syndrome in different subtypes by using UPLC-MS method.
    Liu X; Zhang C; Huang J; Liu H; Li B; Zhang F; Xu C
    Clin Chim Acta; 2024 Apr; 557():117860. PubMed ID: 38508572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry.
    Sun Z; Chang HM; Wang A; Song J; Zhang X; Guo J; Leung PCK; Lian F
    Reprod Biol Endocrinol; 2019 Jun; 17(1):45. PubMed ID: 31186025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disturbed Follicular Microenvironment in Polycystic Ovary Syndrome: Relationship to Oocyte Quality and Infertility.
    Dai M; Hong L; Yin T; Liu S
    Endocrinology; 2024 Feb; 165(4):. PubMed ID: 38375912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome.
    Qian Y; Tong Y; Zeng Y; Huang J; Liu K; Xie Y; Chen J; Gao M; Liu L; Zhao J; Hong Y; Nie X
    J Transl Med; 2024 Apr; 22(1):364. PubMed ID: 38632610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyper response to ovarian stimulation affects the follicular fluid metabolomic profile of women undergoing IVF similarly to polycystic ovary syndrome.
    Cordeiro FB; Cataldi TR; de Souza BZ; Rochetti RC; Fraietta R; Labate CA; Lo Turco EG
    Metabolomics; 2018 Mar; 14(4):51. PubMed ID: 30830356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between steroid levels in follicular fluid and hormone synthesis related substances in its exosomes and embryo quality in patients with polycystic ovary syndrome.
    Yu L; Liu M; Wang Z; Liu T; Liu S; Wang B; Pan B; Dong X; Guo W
    Reprod Biol Endocrinol; 2021 May; 19(1):74. PubMed ID: 34001150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular fluid cytokine composition and oocyte quality of polycystic ovary syndrome patients with metabolic syndrome undergoing in vitro fertilization.
    Niu Z; Ye Y; Xia L; Feng Y; Zhang A
    Cytokine; 2017 Mar; 91():180-186. PubMed ID: 28082237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceramide subclasses identified as novel lipid biomarker elevated in women with polycystic ovary syndrome: a pilot study employing shotgun lipidomics.
    Jiang Y; Qi J; Xue X; Huang R; Zheng J; Liu W; Yin H; Li S
    Gynecol Endocrinol; 2020 Jun; 36(6):508-512. PubMed ID: 31793360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and follicular fluid irisin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with insulin resistance and lipoprotein lipid profiles.
    Bousmpoula A; Benidis E; Demeridou S; Kapeta-Kourkouli R; Chasiakou A; Chasiakou S; Kouskouni E; Baka S
    Gynecol Endocrinol; 2019 Sep; 35(9):803-806. PubMed ID: 30982370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome.
    Henríquez S; Kohen P; Xu X; Villarroel C; Muñoz A; Godoy A; Strauss JF; Devoto L
    Hum Reprod; 2020 Jul; 35(7):1655-1665. PubMed ID: 32558920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic profile of follicular fluid from patients with polycystic ovary syndrome (PCOS) submitted to in vitro fertilization (IVF) compared to oocyte donors.
    Domingues TS; Bonetti TC; Pimenta DC; Mariano DOC; Barros B; Aquino AP; Motta ELA
    JBRA Assist Reprod; 2019 Oct; 23(4):367-391. PubMed ID: 31173497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular fluid lipid fingerprinting from women with PCOS and hyper response during IVF treatment.
    Cordeiro FB; Cataldi TR; do Vale Teixeira da Costa L; de Lima CB; Stevanato J; Zylbersztejn DS; Ferreira CR; Eberlin MN; Cedenho AP; Turco EG
    J Assist Reprod Genet; 2015 Jan; 32(1):45-54. PubMed ID: 25374394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
    Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
    Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Lipidomic Signature Associated With Metabolic Risk in Women With and Without Polycystic Ovary Syndrome.
    Mousa A; Huynh K; Ellery SJ; Strauss BJ; Joham AE; de Courten B; Meikle PJ; Teede HJ
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1987-e1999. PubMed ID: 34971378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered redox status may contribute to aberrant folliculogenesis and poor reproductive outcomes in women with polycystic ovary syndrome.
    Naigaonkar A; Dadachanji R; Hinduja I; Mukherjee S
    J Assist Reprod Genet; 2021 Oct; 38(10):2609-2623. PubMed ID: 34041658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.